Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Q4 2020 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Mar 02, 2021 / 10:00PM GMT
Release Date Price: $35.06 (-3.87%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Maravai LifeSciences' Q4 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your host, Senior Director, Investor Relations, Debra Hart. Madam, you may begin.

Debra Hart
Maravai LifeSciences Holdings, Inc. - Senior Director of IR

Thank you, Latif. Good afternoon, everyone. Thanks for joining us on our first quarterly earnings call as a public company. On today's call, we will cover our financial results and business highlights for Maravai's fourth quarter and full year 2020, and we'll provide financial guidance for 2021.

Our CEO, Carl Hull, will first provide a business update; and our CFO, Kevin Herde, will review our financial results and guidance. Our President, Eric Tardif, is joining us, along with Carl and Kevin to answer questions following the prepared remarks.

As a reminder, the forward-looking statements that we make during this call,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot